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In a paper in the previous issue of Arthritis Research and 
Th  erapy Angyal and colleagues [1] ask the fundamental 
question of how and where T cells contribute to arthritis 
pathogenesis. Th  at T cells do contribute to arthritis 
patho  genesis is widely accepted: HLA-DRB1 is the best-
established genetic locus inﬂ  uencing rheumatoid arthritis 
(RA); and other genetic risk factors, including PTPN22, 
are also relevant for T-cell function [2]. Abatacept, which 
blocks T-helper (Th  ) cell co-stimulation, is an eﬀ  ective 
treatment for RA patients [3]. Nonetheless, the speciﬁ  city 
of pathogenic T cells in RA remains unknown. Increasing 
evidence suggests that recognition of systemically 
expressed antigens by T cells can induce arthritis. Systemic 
autoimmune responses towards glucose-6-phosphate 
isomerase [4,5], ﬁ  brinogen [6], or transgenically expressed 
hemagglutinin [7] induce arthritis in mice. Moreover, 
systemic alterations that impact on T-cell reactivity result 
in arthritis. Th  e so-called SKG mice and gp130 mutant 
mice spontaneously develop chronic joint inﬂ  ammation 
[8]. In both models particular arthritogenic autoantigens 
have not been identiﬁ  ed. Instead, T cell receptor signaling 
is altered in SKG mice, resulting in a broad repertoire of 
low-aﬃ   nity autoreactive T cells. Autoimmunity towards 
systemically expressed antigens might well be relevant in 
human arthritis. Adaptive immune responses to 
citrullinated peptides are a hallmark of RA and the origin 
of the recognized citrullinated peptides is not restricted 
to joint-speciﬁ  c antigens [2]. Taken together, mounting 
evidence puts into question the notion that arthritogenic 
antigens must be joint-speciﬁ  c.
It is against this background that Angyal and colleagues 
[1] asked where the pathogenic T cells in arthritis exert 
eﬀ  ector functions. After immunizing with proteoglycan, 
they obtained spleen cells from arthritic mice, labeled the 
T cells with a ﬂ  uorescent dye, and transferred the labeled 
T cells together with the antigen-presenting cells into 
SCID (severe combined immunodeﬁ   cient) mice. Next, 
they used multi-photon microscopy to identify the trans-
ferred T cells in the recipients’ ankle joint and lymph 
nodes. Whereas T cells were demonstrable in lymph nodes 
for at least 12 days after transfer, very few were detectable 
in the joint.
Where, then, do the pathogenic T cells act? To address 
this, the authors transferred either whole spleen cells, or 
spleen cells depleted of T lymphocytes into recipient 
mice. One group of mice receiving whole spleen cells was 
treated with FTY720, an agonist of the phospholipid 
sphingosine 1 phosphate, which sequesters lymphocytes 
in lymph nodes and peripheral tissues. Arthritis 
developed in the recipients of whole spleen cells regard-
less of whether the recipients received FTY720 or not. 
Th   e number of T cells in the secondary lymphatic organs 
and the titers of IgG1 antibodies against proteo  glycan 
were similar in the FTY720-treated and control mice. In 
contrast, the recipients of T-cell-depleted splenocytes 
were protected from arthritis and lacked IgG1 antibodies 
against proteoglycan. Angyal and colleagues conclude 
that the T lymphocytes’ function in proteoglycan-
induced arthritis is to provide help for the production of 
pathogenic antibodies, mirroring earlier ﬁ  ndings in the 
K/BxN arthritis model [4].
Although interesting and provocative, these data do 
not rule out the possibility that T cells in the joint are 
required for development of proteoglycan-induced 
arthritis. Few T cells were detectable in the joints 12 days 
after the adoptive transfer of spleen cells. However, at 
Abstract
T-helper (Th) lymphocytes contribute to arthritis 
pathogenesis by helping B cells to produce antibodies, 
by producing cytokines that activate eff  ector cells 
involved in the destruction of cartilage and bone, and 
by contributing to osteoclast diff  erentiation. There 
are murine models of arthritis, most notably collagen- 
and proteoglycan-induced arthritis, in which arthritis 
depends on T-cell recognition of antigens that are 
expressed in the joints. In spite of this, we still do not 
know the antigens recognised by arthritogenic Th cells 
in humans. Moreover, current evidence for Th cells 
exerting arthritogenic eff  ector functions within the 
joints is only indirect.
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clinical signs of arthritis mild. Could it be that pathogenic 
T cells egress into the joint later in the course of disease, 
that is, immediately before the onset of arthritis? Th  is 
was shown in earlier work in the collagen-induced 
arthritis model [9]. Treating recipient mice with FTY720 
after adoptive cell transfer also has its pitfalls: FTY720 
prevents the exit of lymphocytes from the lymph nodes 
as well as their exit from the target tissue [10]. Th  us, 
eﬀ  ector/memory cells adoptively transferred intra  venously 
can move directly into the joint before being trapped in 
the lymph nodes by FTY720. In fact, while FTY720 
treatment reduced the numbers of T cells in the joint, 
this reduction did not reach statistical signiﬁ  cance [1]. 
Th   us, it may be too early to dismiss a role for local T cell 
action in arthritis.
On the other hand, current evidence that pathogenic 
T cells need to exert eﬀ  ector functions within the joints is 
indirect. Synovial tissue from RA patients contains 
T cells, B cells and dendritic cells and sometimes also 
lymphoid follicles with germinal-center-like structures 
[2]. T cells from synovial tissue can produce cytokines 
such as IL-17, which are relevant for arthritis patho-
genesis. It is unclear, however, if T cells recognize antigen 
within the joint. T cells obtained from synovial tissue 
have a peculiar phenotype compatible with their activa-
tion by cytokines rather than antigen recognition. 
Whatever triggers the local activation of T cells within 
the joints, synovial ﬁ  broblasts are exquisitely sensitive for 
IL-17 and other T-cell-derived cytokines [2]. Angyal and 
colleagues have demonstrated in a series of elegant 
experiments that we still do not know where T cells exert 
their arthritogenic functions. Th  is topic clearly merits 
further investigations.
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